Aspira Pathlab & Diagnostics' Stock Surges, Outperforms Sector and Sensex in Strong 1-Year Performance
Aspira Pathlab & Diagnostics, a microcap company in the healthcare industry, has seen a significant increase in its stock price, reaching a 52-week high of Rs. 54.46 on October 24, 2024. The stock has outperformed the sector and consistently traded above its moving averages, showcasing its strong performance and potential in the market.
Aspira Pathlab & Diagnostics, a microcap company in the hospital and healthcare services industry, has recently seen a surge in its stock price. On October 24, 2024, the company's stock reached a 52-week high of Rs. 54.46. This has caught the attention of investors and market analysts, with MarketsMOJO giving a 'Sell' call for the stock.
The stock has been performing well in the past few days, outperforming the sector by 1.64%. It has also seen a consecutive gain for the last 4 days, with a 15.87% increase in returns during this period. Today, the stock opened with a gain of 2% and touched an intraday high of Rs. 54.46.
Aspira Pathlab & Diagnostics has been consistently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its stock price.
In comparison to the Sensex's performance of 23.93%, Aspira Pathlab & Diagnostics has shown a strong 1-year performance of 46.63%. This showcases the company's growth and potential in the healthcare industry.
Investors and market experts are closely monitoring the performance of Aspira Pathlab & Diagnostics, as it continues to make strides in the market. With its recent surge in stock price and positive performance, the company is definitely one to watch in the healthcare sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
